Blaschke Michael, Zehl Martin, Hartl Beatrix, Strauß Claudia, Winkler Johannes, Urban Ernst, Krupitza Georg, Kopp Brigitte
Department of Pharmacognosy, University of Vienna, Althanstraße 14, 1090 Vienna, Austria; Institute of Clinical Pathology, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.
Department of Pharmacognosy, University of Vienna, Althanstraße 14, 1090 Vienna, Austria; Department of Pharmaceutical Chemistry, University of Vienna, Althanstraße 14, 1090 Vienna, Austria; Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Währinger Straße 38, 1090 Vienna, Austria.
Phytochemistry. 2017 Sep;141:37-47. doi: 10.1016/j.phytochem.2017.05.009. Epub 2017 May 26.
The traditionally used Central American medicinal plant Pluchea odorata, known as an anti-inflammatory and cancer cell growth-inhibiting remedy, was subjected to bioassay-guided isolation. Structure elucidation by 1D- and 2D-NMR and MS techniques supported by ECD and UV spectroscopic data revealed seven structurally previously undescribed and eight known eudesmane-type sesquiterpenes. Furthermore, one previously undescribed and one known phytol-like alcohol were identified. All compounds were tested for their cytotoxicity in cancer cells and for their anti-invasive effects. Among the eudesmanes, 3α-(2',3'-epoxy-2'-methylbutyryloxy)-4α-hydroxy-11-hydroperoxy-eudesm-6-en-8-one exhibited the most potent cytotoxic activity with an IC value of 8.8 μM (after 48 h). Also in an in vitro model measuring the tumor-triggered breaching of the adjacent lymph endothelial cell barrier (3S*,4R*,5S*,10S*,2'R*,3'R*)-3-(2',3'-epoxy-2'-methylbutyryloxy)-4,7-dihydroxy-eudesm-11-en-8-one (IC = 47 μM) and (3S*,4R*,5R*,10S*,2'R*,3'R*)-3-(2',3'-epoxy-2'-methylbutyryloxy)-4-acetyloxy-6-methoxy-11-hydroxy-eudesm-6-en-8-one (IC = 73 μM) showed inhibitory activities. Furthermore, preliminary structure-activity relationships (SARs) of the eudesmanes were developed.
传统上使用的中美洲药用植物香胶蒲,作为一种抗炎和抑制癌细胞生长的药物,进行了生物测定指导下的分离。通过一维和二维核磁共振以及质谱技术,并得到电子圆二色光谱和紫外光谱数据的支持进行结构解析,结果显示有7种结构上以前未描述过的和8种已知的桉叶烷型倍半萜。此外,还鉴定出一种以前未描述过的和一种已知的植醇类醇。所有化合物都测试了其对癌细胞的细胞毒性及其抗侵袭作用。在桉叶烷类化合物中,3α-(2',3'-环氧-2'-甲基丁酰氧基)-4α-羟基-11-氢过氧-桉叶-6-烯-8-酮表现出最强的细胞毒性活性,其IC值为8.8 μM(48小时后)。同样在一个体外模型中,测量肿瘤引发的相邻淋巴管内皮细胞屏障的破坏情况,(3S*,4R*,5S*,10S*,2'R*,3'R*)-3-(2',3'-环氧-2'-甲基丁酰氧基)-4,7-二羟基-桉叶-11-烯-8-酮(IC = 47 μM)和(3S*,4R*,5R*,10S*,2'R*,3'R*)-3-(2',3'-环氧-2'-甲基丁酰氧基)-4-乙酰氧基-6-甲氧基-11-羟基-桉叶-6-烯-8-酮(IC = 73 μM)显示出抑制活性。此外,还建立了桉叶烷类化合物的初步构效关系(SARs)。